27687332|t|Complicated function of dopamine in Abeta-related neurotoxicity: Dual interactions with Tyr10 and SNK(26-28) of Abeta.
27687332|a|With the capability to inhibit the formation of amyloid beta peptides (Abeta) fibril, dopamine (DA) and other catechol derivatives have been considered for the potential treatment of Alzheimer's disease (AD). Such treatment, however, remains debatable because of the diverse functions of Abeta and DA in AD pathology. Moreover, the complicated oxidation accompanying DA has caused the majority of the previous research to focus on the binding of DA oxides onto Abeta. The molecular mechanism by which Abeta interacts with the reduction state of DA, which is correlative with the brain function, should be urgently explored. By controlling rigorous anaerobic experimental conditions, this work investigated the molecular mechanism of the Abeta/DA interaction, and two binding sites were revealed. For the binding of DA, Tyrosine (Tyr10) was identified as the strong binding site, and serine-asparagine-lysing (SNK(26-28)) segment was the weak binding segment. Furthermore, the Thioflavin T (THT) fluorescence confirmed DA's positive function of inhibiting Abeta aggregation through its weakly binding with SNK(26-28) segment. Meanwhile, 7-OHCCA fluorescence exhibited DA's negative function of enhancing OH generation through inhibiting the Abeta/Cu2+ coordination. The viability tests of the neuroblastoma SH-SY5Y cells displayed that the coexistence of DA, Cu2+, and Abeta induced lower cell viability than free Cu2+, indicating the significant negative effect of excessive DA on AD progression. This research revealed the potential DA-induced damage in AD brain, which is significant for understanding the function of DA in AD neuropathology and for designing a DA-related therapeutic strategy for AD.
27687332	24	32	dopamine	Chemical	MESH:D004298
27687332	36	41	Abeta	Gene	351
27687332	50	63	neurotoxicity	Disease	MESH:D020258
27687332	112	117	Abeta	Gene	351
27687332	190	195	Abeta	Gene	351
27687332	205	213	dopamine	Chemical	MESH:D004298
27687332	215	217	DA	Chemical	MESH:D004298
27687332	229	237	catechol	Chemical	MESH:C034221
27687332	302	321	Alzheimer's disease	Disease	MESH:D000544
27687332	323	325	AD	Disease	MESH:D000544
27687332	407	412	Abeta	Gene	351
27687332	417	419	DA	Chemical	MESH:D004298
27687332	423	425	AD	Disease	MESH:D000544
27687332	486	488	DA	Chemical	MESH:D004298
27687332	565	574	DA oxides	Chemical	-
27687332	580	585	Abeta	Gene	351
27687332	620	625	Abeta	Gene	351
27687332	664	666	DA	Chemical	MESH:D004298
27687332	856	861	Abeta	Gene	351
27687332	862	864	DA	Chemical	MESH:D004298
27687332	934	936	DA	Chemical	MESH:D004298
27687332	1095	1107	Thioflavin T	Chemical	MESH:C009462
27687332	1109	1112	THT	Chemical	MESH:C009462
27687332	1137	1139	DA	Chemical	MESH:D004298
27687332	1174	1179	Abeta	Gene	351
27687332	1224	1234	SNK(26-28)	Chemical	-
27687332	1255	1262	7-OHCCA	Chemical	MESH:C106879
27687332	1286	1288	DA	Chemical	MESH:D004298
27687332	1359	1364	Abeta	Gene	351
27687332	1365	1369	Cu2+	Chemical	-
27687332	1411	1424	neuroblastoma	Disease	MESH:D009447
27687332	1425	1432	SH-SY5Y	CellLine	CVCL:0019
27687332	1473	1475	DA	Chemical	MESH:D004298
27687332	1477	1481	Cu2+	Chemical	-
27687332	1487	1492	Abeta	Gene	351
27687332	1532	1536	Cu2+	Chemical	-
27687332	1594	1596	DA	Chemical	MESH:D004298
27687332	1600	1602	AD	Disease	MESH:D000544
27687332	1653	1655	DA	Chemical	MESH:D004298
27687332	1674	1682	AD brain	Disease	MESH:D000544
27687332	1739	1741	DA	Chemical	MESH:D004298
27687332	1745	1747	AD	Disease	MESH:D000544
27687332	1783	1785	DA	Chemical	MESH:D004298
27687332	1819	1821	AD	Disease	MESH:D000544
27687332	Association	MESH:D020258	351
27687332	Negative_Correlation	MESH:C106879	351
27687332	Negative_Correlation	MESH:C034221	MESH:D000544
27687332	Negative_Correlation	MESH:D004298	351
27687332	Association	MESH:D004298	MESH:D020258
27687332	Negative_Correlation	MESH:D004298	MESH:D000544
27687332	Association	MESH:D000544	351
27687332	Association	MESH:C106879	MESH:D004298

